Cyclic peptides have received increasing attention over the recent years as potential therapeutics for “undruggable” targets. One major obstacle is, however, their often relatively poor bioavailability. Here, we investigate the structure–permeability relationship of 24 cyclic decapeptides that share the same backbone N-methylation pattern but differ in their side chains. The peptides cover a large range of values for passive membrane permeability as well as lipophilicity and solubility. To rationalize the observed differences in permeability, we extracted for each peptide the population of the membrane-permeable conformation in water from extensive explicit-solvent molecular dynamics simulations and used this as a metric for conformational ...
Research into macrocycles as an emerging class of pharmaceutically relevant molecules has increased ...
Cyclic peptides and macrocycles have the potential to be membrane permeable and orally bioavailable,...
Cyclic peptides are able to extend the druggable space of pharmaceutical targets, due to their size,...
Cyclic peptides have received increasing attention over the recent years as potential therapeutics f...
Cyclic peptides have received increasing attention over the recent years as potential therapeutics f...
Cyclization and selected backbone N-methylations are found to be often necessary but not sufficient ...
Cyclization and selected backbone N-methylations are found to be often necessary but not sufficient ...
Cyclization and selected backbone N-methylations are found to be often necessary but not sufficient ...
Proteins with large and flat binding sites as well as protein–protein interactions are considered ' ...
Proteins with large and flat binding sites as well as protein–protein interactions are considered ' ...
Proteins with large and flat binding sites as well as protein–protein interactions are considered ' ...
Proteins with large and flat binding sites as well as protein–protein interactions are considered ' ...
Cyclic peptides have the potential to vastly extend the scope of druggable proteins and lead to new ...
Cyclic peptides are structurally complex molecules with the potential to access challenging biologic...
Many cyclic peptide natural products are larger and structurally more complex than conventional smal...
Research into macrocycles as an emerging class of pharmaceutically relevant molecules has increased ...
Cyclic peptides and macrocycles have the potential to be membrane permeable and orally bioavailable,...
Cyclic peptides are able to extend the druggable space of pharmaceutical targets, due to their size,...
Cyclic peptides have received increasing attention over the recent years as potential therapeutics f...
Cyclic peptides have received increasing attention over the recent years as potential therapeutics f...
Cyclization and selected backbone N-methylations are found to be often necessary but not sufficient ...
Cyclization and selected backbone N-methylations are found to be often necessary but not sufficient ...
Cyclization and selected backbone N-methylations are found to be often necessary but not sufficient ...
Proteins with large and flat binding sites as well as protein–protein interactions are considered ' ...
Proteins with large and flat binding sites as well as protein–protein interactions are considered ' ...
Proteins with large and flat binding sites as well as protein–protein interactions are considered ' ...
Proteins with large and flat binding sites as well as protein–protein interactions are considered ' ...
Cyclic peptides have the potential to vastly extend the scope of druggable proteins and lead to new ...
Cyclic peptides are structurally complex molecules with the potential to access challenging biologic...
Many cyclic peptide natural products are larger and structurally more complex than conventional smal...
Research into macrocycles as an emerging class of pharmaceutically relevant molecules has increased ...
Cyclic peptides and macrocycles have the potential to be membrane permeable and orally bioavailable,...
Cyclic peptides are able to extend the druggable space of pharmaceutical targets, due to their size,...